CDT — Conduit Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $6.09m
- $12.76m
Annual cashflow statement for Conduit Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -3.66 | -4.89 | -0.535 | -17.8 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 0.149 | 2.02 | -4.67 | 7.8 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 1.36 | 0.596 | -2.52 | -0.142 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -2.15 | -2.27 | -7.72 | -9.68 |
| Capital Expenditures | — | — | — | -0.051 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | -0.183 | 0.725 | 0.008 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | -0.183 | 0.725 | -0.043 |
| Financing Cash Flow Items | — | — | 8.64 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.9 | 2.45 | 10.9 | 6.07 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.252 | 0 | 4.23 | -3.67 |